Symptom Spectrum and the Evaluation of Severity and Duration | 83195

Journal of Research in Medical and Dental Science
eISSN No. 2347-2367 pISSN No. 2347-2545

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Symptom Spectrum and the Evaluation of Severity and Duration of Symptoms in Patients with COVID-19

Author(s): Senol Dane* and Murat Akyuz


Introduction: In the present study, three aims were targeted, (1) Determination of symptom spectrum and the evaluation of severity and duration of symptoms in patients with COVID-19, (2) Determination of the effects of some demographic characteristics on symptom severity and duration and (3) Determination of the effects of race (Nigerians and expats) and (4) age group. Materials and Method: Subjects were those who experienced COVID-19 and recovered. Eighty-one subjects were included in the study. All of them accepted to participate in this study (51 men and 30 women). Out of 81 cases, 48 were expat and 33 were Nigerian. Data was collected by using an online survey. The survey was shared by using social media. Results: The severities of generalized body pain, loss of smell, fatigue, headache were moderate or severe. The duration of generalized body pain, loss of smell and fatigue were higher than 1-3 days. Some symptoms were higher in women than in men. There was no race related in symptom severity or duration. Only breath difficulty was higher in 35-45 age group. Conclusion: These results show that COVID-19 cases in Nigeria are quite low compared to other world countries. In general, the severities and durations of COVID-19 symptoms were so weak.

Share this article